JDRF

JDRF
Name	JDRF
Type	Nonprofit
Founded	1970
Founder	Sylvia Allen, Gary Duff, Amaranth and Mark Richards
Headquarters	New York City
Area served	International
Focus	Type 1 diabetes research

JDRF JDRF is a global nonprofit organization focused on accelerating research to cure and treat type 1 diabetes. Founded in 1970 by families affected by childhood diabetes, the organization funds scientific programs, advocates for public policy, and organizes fundraising events. It collaborates with academic institutions, biotechnology firms, and health agencies to translate basic research into clinical therapies.

History

The organization traces its origins to families in New York City and Connecticut who formed a grassroots group after the diagnosis of children in the late 1960s. Early activities paralleled developments at institutions such as Massachusetts General Hospital, Johns Hopkins Hospital, and Mayo Clinic where pediatric endocrinology was advancing. During the 1970s and 1980s the organization built networks with researchers at Harvard University, University of California, San Francisco, Stanford University, and Yale University to support clinical research. In the 1990s and 2000s it expanded partnerships with biotechnology companies including Genentech, Amgen, and Novo Nordisk while engaging regulatory bodies like the Food and Drug Administration and funding initiatives at agencies such as the National Institutes of Health. Milestones include sponsoring early trials in immunotherapy and beta cell replacement research that involved collaborations with teams at University of Oxford, Karolinska Institutet, and University of Melbourne.

Mission and Activities

The organization’s stated mission emphasizes accelerating progress toward cures and improved therapies for type 1 diabetes through research funding, advocacy, and community engagement. Programmatic activities often intersect with academic centers such as Columbia University, University of Pennsylvania, and Imperial College London, industry partners like Medtronic and Roche, and foundations including the Bill & Melinda Gates Foundation and the Wellcome Trust. Patient-centered activities have linked the organization with clinical networks including the Type 1 Diabetes Exchange and international consortia such as the Diabetes TrialNet and the International Diabetes Federation.

Research Funding and Programs

Research investments target immune modulation, beta cell transplantation, artificial pancreas systems, and prevention strategies. Funding mechanisms have supported investigators at Stanford University School of Medicine, University of Cambridge, Mount Sinai Health System, Karolinska University Hospital, and Johns Hopkins University School of Medicine. Large-scale initiatives have included clinical trial networks, biomarker discovery collaborations with groups at Broad Institute, and translational partnerships with firms such as Vertex Pharmaceuticals and Intarcia Therapeutics. Notable programmatic emphases have been on technologies developed by teams at Massachusetts Institute of Technology, engineering collaborations with Georgia Institute of Technology, and bioengineering efforts with University of Washington. The organization has funded trials involving immunotherapies tested by researchers affiliated with Stanford Medical School, Yale School of Medicine, and Duke University School of Medicine and has supported efforts in stem cell research connected to University of California, San Diego and Harvard Stem Cell Institute.

Advocacy and Policy

Advocacy priorities include access to insulin, affordability initiatives, and research funding appropriations. The group has lobbied legislators and worked with agencies such as the Centers for Medicare & Medicaid Services, the Department of Health and Human Services, and lawmakers in the United States Congress to influence health policy. It has coordinated advocacy with national organizations like American Diabetes Association and international partners such as Juvenile Diabetes Research Foundation International affiliates and has engaged coalitions including PatientsLikeMe and Rare Diseases Clinical Research Network for policy campaigns. Public campaigns have been timed around hearings in bodies like the U.S. Senate Committee on Health, Education, Labor, and Pensions and budget discussions at the Office of Management and Budget.

Organizational Structure and Leadership

The organization operates with a board of directors, scientific advisory councils, and international affiliate offices. Leadership teams have included executives with prior roles at nonprofits such as American Red Cross and corporations including Pfizer and Johnson & Johnson. Scientific advisory panels draw experts from institutions like University of Chicago, Northwestern University, Karolinska Institutet, and University of Toronto to assess strategic research priorities. Regional chapters coordinate volunteer networks modeled after community fundraising structures used by organizations like Susan G. Komen and American Heart Association. Governance practices reference nonprofit standards advanced by groups such as Independent Sector and GuideStar.

Fundraising and Events

Fundraising relies on signature events, peer-to-peer campaigns, and major donor programs. Recurring events have included walks, galas, and community challenges similar to those organized by Make-A-Wish Foundation and St. Jude Children's Research Hospital. Corporate partnerships have involved collaborations with companies like Target Corporation, Citi, Microsoft, and Amazon for cause marketing and employee giving. Fundraising efforts have supported landmark investments in trials conducted at centers such as Cleveland Clinic, Children's Hospital of Philadelphia, and Boston Children's Hospital and have engaged celebrity advocates and ambassadors connected to entertainment institutions such as The Academy Awards and sports organizations like the National Basketball Association.

Category:Medical research foundations